Modulation of virus-specific immunity in vitro by the addition of interleukin-1 and interleukin-2 in patients with the acquired immune deficiency syndrome.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000328:Adult; D000704:Analysis of Variance; D000956:Antigens, Viral / Q000276:immunology*; D003587:Cytomegalovirus / Q000276:immunology*; D006801:Humans; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000276:immunology* / Q000494:pharmacology; D007376:Interleukin-2 / Q000276:immunology* / Q000494:pharmacology; D008223:Lymphoma / Q000276:immunology*; D008297:Male; D011043:Pokeweed Mitogens / Q000276:immunology; D018139:Simplexvirus / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000956:Antigens, Viral; D007375:Interleukin-1; D007376:Interleukin-2; D011043:Pokeweed Mitogens